Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 HKEX Human health and social work activities
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-06 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2026-04-24 English
2025 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is explicitly titled '2025 Annual Report' for Yunkang Group Limited. It contains comprehensive sections including corporate information, financial highlights, chairman's statement, management discussion and analysis, and consolidated financial statements (audited). It meets all criteria for an Annual Report (10-K equivalent for non-US jurisdictions). FY 2025
2026-04-24 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings Classification · 1% confidence The document is a monthly regulatory return to the Hong Kong Exchange (HKEX) reporting movements in authorized share capital, issued shares, public float sufficiency, and confirmations. It does not announce dividends, capital raises, management changes, or full financial reports. It is not a standalone financial report (e.g., 10-K, IR) but a listing rule compliance submission. Therefore, it falls under the general regulatory filings category (RNS).
2026-04-02 English
PROPOSED ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is an official announcement under the Hong Kong Listing Rules, proposing amendments to and adoption of new Memorandum & Articles of Association. It is not a proxy statement, financial results release, or other report, but rather a corporate governance change to the company’s internal rules. This aligns with the Governance Information category.
2026-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
Earnings Release Classification · 1% confidence The document is titled “ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025” and contains the Board’s consolidated financial results, key highlights, complete sets of consolidated financial statements and notes. It is an initial public announcement of the year‐end results rather than the company’s full Annual Report (which would include management discussion & analysis, corporate governance, auditor’s opinion, and other sections). Therefore it best fits the Earnings Release category (initial announcement of periodical financial results). FY 2025
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.